Walgreens Boots Alliance (WBA) closed the most recent trading day at $9.70, moving -0.51% from the previous trading session.
Walgreens Boots Alliance is getting closer to selling its stake in doctor-staffed clinic operator VillageMD, which has already cost the drugstore giant billions of dollars.
Walgreens Boots Alliance-backed healthcare clinic chain VillageMD is reportedly working with advisers to explore a sale, restructuring or other options. This move comes after Walgreens CEO Tim Wentworth said during a January earnings call that the company plans to divest VillageMD, Bloomberg reported Wednesday (Feb. 12).
Walgreens is set to close five locations across Los Angeles and Orange counties in the coming weeks -- a move that could result in at least 93 job losses.
Walgreens Boots Alliance (WBA -6.12%) faces an uncertain path ahead. Its financials haven't been strong in recent years, and its struggling pharmaceutical operations face growing competition.
Investors drawn to WBA and CVS must feel disappointed. WBA's recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. I won't consider either as a buy candidate.
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $10.12, indicating a +0.7% shift from the previous trading day.
The latest trading day saw Walgreens Boots Alliance (WBA) settling at $9.89, representing a +1.33% change from its previous close.
Investors in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) have experienced a rollercoaster ride in 2025. After a 25% surge earlier this month, driven by strong Q1 2025 earnings and revenue that beat expectations, the company's stock is now down over 15% in early trading today.
Walgreens Boots Alliance, Inc. investors have had a wild 2025 so far. Earlier this month, the beleaguered stock (Nasdaq: WBA) soared 25% after beating Q1 2025 expectations on revenue and earnings per share.
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) (WBA) shares tumbled more than 12% after the pharmacy chain announced the suspension of its quarterly cash dividend in a bid to conserve cash amid financial pressures. The company faces a lawsuit from the US Department of Justice which accuses it of dispensing millions of unlawful prescriptions and needs to refinance its debt.
Walgreens Boots Alliance (WBA) shares are sinking in premarket trading, as the pharmacy chain suspends quarterly dividends to shore up its finances while it works to turnaround its business.